MD Pediatrix Medical Group, Inc. Common Stock
$26.09
价格 · 八月 19, 2026
截至...的财报数据 八月 4, 2026
52周区间
$16–$28
85% of range
分析师评级
HOLD
15 analysts
目标价
$26
+0% upside
P/E (TTM)
13.4
ROE
20.3%
净利润率
8.6%
关于 Pediatrix Medical Group, Inc. Common Stock 公司概况（来自维基百科）
MD 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$26.09
市值
$2.16B
P/E (TTM)
13.4
每股收益 (TTM)
$1.94
营收 (TTM)
$1.91B
股息收益率
—
ROE
20.3%
负债/权益
—
52周区间
$16 – $28
MD 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$1.91B
2016-12-31
→
2025-12-31
EPS
$1.94
2016-12-31
→
2025-12-31
自由现金流
—
利润率
8.6%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
MD
同行中位数
P/E (TTM)
13.4
35.7
P/S (TTM) (市销率 (TTM))
1.1
1.2
P/B (市净率)
2.5
3.1
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
MD
同行中位数
Operating Margin (营业利润率)
10.9%
—
Net Profit Margin (净利润率)
8.6%
2.3%
ROA
7.5%
4.3%
ROE
20.3%
6.6%
ROIC
18.4%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
MD
同行中位数
Current Ratio (流动比率)
1.7
1.5
Quick Ratio (速动比率)
1.3
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
MD
同行中位数
Revenue YoY (营收同比增长)
-4.9%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-0.99%
—
Revenue CAGR 5Y (营收5年复合年增长率)
2.0%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
MD
同行中位数
MD 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
15 位分析师
- 强烈买入 5 33.3%
- 买入 4 26.7%
- 持有 6 40.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
6 位分析师 · 2026-08-17
中位数
$27.50
平均值
$26.17
现在
$26.09
最低
$21.00
最高
$28.00
中位数目标
$27.50
+5.4%
平均目标
$26.17
+0.3%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.06%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.63 | $0.61 | 0.02% |
| 2026年3月31日 | $0.44 | $0.39 | 0.05% |
| 2025年12月31日 | $0.50 | $0.56 | -0.06% |
| 2025年9月30日 | $0.67 | $0.48 | 0.19% |
| 2025年6月30日 | $0.53 | $0.44 | 0.09% |
| 2025年3月31日 | $0.33 | $0.25 | 0.08% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| PRVA | $2.93B | 131.7 | 22.3% | 1.1% | 3.3% | — |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B | $1.73B | $1.78B | $1.72B | $3.25B | $3.18B | |
| SG&A Expense | $241M | $238M | $228M | $231M | $263M | $249M | $245M | $232M | $386M | $373M | |
| Operating Expenses | $1.71B | $2.08B | $1.99B | $1.80B | $1.71B | $1.64B | $1.61B | $1.47B | $2.80B | $2.61B | |
| Operating Income | $209M | $-69M | $7M | $173M | $203M | $98M | $172M | $248M | $455M | $572M | |
| Interest Expense | · | · | $42M | $40M | $69M | $110M | $119M | $93M | $75M | $63M | |
| Other Non-op | $8M | $-33M | $-56M | $-91M | $-68M | $-91M | $-113M | $-82M | $-69M | $-58M | |
| Pretax Income | $216M | $-101M | $-48M | $81M | $135M | $7M | $59M | $166M | $386M | $514M | |
| Income Tax | $51M | $-2M | $12M | $19M | $27M | $17M | $17M | $45M | $80M | $189M | |
| Net Income | $165M | $-99M | $-60M | $66M | $131M | $-796M | $-1.50B | $269M | $320M | $325M | |
| EPS (Basic) | $1.97 | $-1.19 | $-0.73 | $0.79 | $1.54 | $-9.55 | $-17.94 | $2.95 | $3.47 | $3.52 | |
| EPS (Diluted) | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 | $-9.55 | $-17.83 | $2.93 | $3.45 | $3.49 | |
| Shares (Basic) | 84,435,000 | 83,330,000 | 82,201,000 | 83,467,000 | 84,832,000 | 83,395,000 | 83,495,000 | 91,104,000 | 92,431,000 | 92,422,000 | |
| Shares (Diluted) | 85,430,000 | 83,330,000 | 82,201,000 | 84,121,000 | 85,828,000 | 83,395,000 | 84,011,000 | 91,606,000 | 92,958,000 | 93,109,000 | |
| EBITDA | $231M | $-36M | $43M | $208M | $235M | $127M | · | $557M | $583M | $661M |
资产负债表 27
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $375M | $230M | $73M | $10M | $387M | $1.12B | $108M | $41M | $40M | $56M | |
| Short-term Investments | · | · | · | · | · | · | $0 | $22M | · | · | |
| Receivables | $230M | $260M | $272M | $297M | $302M | $242M | $434M | $507M | $504M | $495M | |
| Prepaid Expense | $13M | $13M | $14M | $15M | $19M | $17M | $17M | $17M | $16M | $11M | |
| Other Current Assets | $9M | $5M | $12M | $13M | $19M | $62M | $12M | $17M | $37M | $14M | |
| Current Assets | $764M | $640M | $483M | $428M | $841M | $1.55B | $732M | $660M | $627M | $587M | |
| PP&E (Net) | $39M | $39M | $76M | $73M | $70M | $76M | $73M | $90M | $124M | $103M | |
| PP&E (Gross) | $172M | $166M | $218M | $246M | $235M | $237M | $226M | $271M | $293M | $247M | |
| Accum. Depreciation | $132M | $127M | $143M | $172M | $165M | $160M | $153M | $181M | $170M | $144M | |
| Goodwill | $1.26B | $1.24B | $1.38B | $1.53B | $1.51B | $1.48B | $1.48B | $4.06B | $4.28B | $3.85B | |
| Intangibles | $17M | $12M | $21M | $18M | $22M | $27M | $29M | $313M | $640M | $669M | |
| Other Non-current Assets | $58M | $77M | $82M | $123M | $131M | $107M | $49M | $81M | $92M | $57M | |
| Total Assets | $2.25B | $2.15B | $2.22B | $2.35B | $2.72B | $3.35B | $4.15B | $5.94B | $5.87B | $5.34B | |
| Accounts Payable | $37M | $46M | $35M | $32M | $37M | $60M | $35M | $31M | $35M | $28M | |
| Current Liabilities | $459M | $434M | $389M | $427M | $427M | $444M | $542M | $503M | $531M | $449M | |
| Capital Leases | $26M | $32M | $47M | $44M | $41M | $41M | $45M | $0 | $425.0K | $1M | |
| Deferred Tax | $57M | $34M | $34M | $34M | $41M | $62M | $56M | $96M | $148M | $228M | |
| Other Non-current Liabilities | $30M | $33M | $31M | $39M | $42M | $45M | $23M | $32M | $58M | $45M | |
| Total Liabilities | $1.38B | $1.39B | $1.37B | $1.46B | $1.83B | $2.60B | $2.65B | $2.85B | $2.80B | $2.58B | |
| Long-term Debt | · | $611M | $622M | $637M | $990M | $1.70B | $1.70B | $2.00B | $1.85B | $1.70B | |
| Total Debt | · | · | · | · | · | · | · | · | · | $1.70B | |
| Common Stock | $830.0K | $859.0K | $840.0K | $829.0K | $864.0K | $856.0K | $842.0K | $878.0K | $937.0K | $937.0K | |
| Retained Earnings | $-83M | $-249M | $-149M | $-89M | $-155M | $-286M | $510M | $2.09B | $2.05B | $1.79B | |
| AOCI | $610.0K | $-1M | $-2M | $-4M | $1M | $4M | $78.0K | $0 | · | · | |
| Stockholders' Equity | $866M | $765M | $849M | $892M | $896M | $747M | $1.50B | $3.09B | $3.07B | $2.76B | |
| Liabilities + Equity | $2.25B | $2.15B | $2.22B | $2.35B | $2.72B | $3.35B | $4.15B | $5.94B | $5.87B | $5.34B | |
| Shares Outstanding | 82,976,110 | 85,866,000 | 84,018,023 | 82,947,132 | 86,423,000 | 85,593,000 | 84,248,000 | 87,820,000 | 93,721,000 | 93,718,000 |
现金流 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $32M | $36M | $36M | $32M | $28M | $26M | $24M | $79M | $89M | |
| Stock-based Comp | $18M | $12M | $12M | $16M | $19M | $39M | $33M | $37M | $29M | $34M | |
| Deferred Tax | $52M | $-2M | $3M | $-23M | $-31M | $36M | $-56M | $-36M | $-61M | $18M | |
| Amort. of Intangibles | $6M | $7M | $6M | $6M | $8M | $8M | $7M | $7M | $52M | $60M | |
| Restructuring | $22M | $64M | $2M | $27M | $22M | $74M | $61M | $0 | $0 | · | |
| Other Non-cash | $14M | $264M | $146M | $72M | $-74M | $897M | · | $-105M | $119M | $-23M | |
| Operating Cash Flow | $271M | $207M | $137M | $167M | $77M | $205M | $358M | $314M | $511M | $444M | |
| Investing Cash Flow | $-18M | $-35M | $-48M | $-57M | $-53M | $816M | $102M | $-143M | $-577M | $-821M | |
| Stock Issued | $3M | $4M | $5M | $5M | $7M | $7M | $11M | $16M | $23M | $22M | |
| Stock Repurchased | $87M | $2M | $919.0K | $89M | $5M | $8M | $145M | $302M | $70M | $62M | |
| Net Stock Activity | $-83M | $2M | $4M | $-83M | $2M | $-1M | · | $-286M | $-47M | $-40M | |
| Financing Cash Flow | $-107M | $-14M | $-26M | $-488M | $-760M | $-4M | $-393M | $-171M | $90M | $382M | |
| Net Change in Cash | $145M | $157M | $63M | $-378M | $-736M | $1.02B | $67M | $329.0K | $25M | $4M | |
| Taxes Paid | $2M | $5M | $31M | $27M | $55M | $-28M | $86M | $185M | $75M | $176M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.9% | -3.4% | 0.37% | 8.8% | 10.6% | 5.7% | · | 12.2% | · | · | |
| Net Margin | 8.6% | -4.9% | -3.0% | 3.4% | 6.9% | -45.9% | · | 7.4% | · | · | |
| Pretax Margin | 11.3% | -5.0% | -2.4% | 4.1% | 7.1% | 0.41% | · | 10.1% | · | · | |
| EBITDA Margin | 12.0% | -1.8% | 2.2% | 10.6% | 12.3% | 7.3% | · | 15.3% | · | · | |
| ROA | 7.5% | -4.5% | -2.6% | 2.6% | 4.3% | -21.3% | · | 4.5% | 5.7% | 6.6% | |
| ROE | 20.3% | -12.3% | -6.9% | 7.4% | 15.9% | -70.9% | · | 8.7% | 11.0% | 12.5% | |
| ROIC | 18.4% | -8.8% | 1.1% | 14.9% | 18.1% | -17.6% | · | 10.5% | 12.2% | 8.1% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.5 | 1.2 | 1.0 | 2.0 | 3.5 | · | 1.3 | 1.2 | 1.3 | |
| Quick Ratio | 1.3 | 1.1 | 0.9 | 0.7 | 1.6 | 3.1 | · | 1.2 | 1.1 | 1.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.6 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | 0.6 | |
| Interest Coverage | · | · | 0.2 | 4.4 | 3.0 | 0.9 | · | 5.0 | 6.4 | 9.1 |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.9 | 0.8 | 0.6 | 0.5 | · | 0.6 | · | · | |
| Receivables Turnover | 7.8 | 7.6 | 7.0 | 6.6 | 7.0 | 5.1 | · | 7.0 | · | · |
增长率 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.9% | 0.92% | 1.1% | 3.2% | 10.2% | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.99% | 1.7% | 4.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -48.4% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 34.9% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -49.4% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 35.6% | · | · | · | · | · | · | · | · | · |
估值 (TTM) 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B | $1.73B | $1.78B | $1.72B | $3.25B | $3.18B | |
| Net Income TTM | $165M | $-99M | $-60M | $66M | $131M | $-796M | $-1.50B | $269M | $320M | $325M | |
| Market Cap | $1.77B | $1.13B | $781M | $1.23B | $2.33B | $2.10B | · | $2.90B | $5.01B | $6.25B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $7.89B | |
| P/E | 11.0 | -11.0 | -12.7 | 18.8 | 17.8 | -2.6 | -1.6 | 11.3 | 15.5 | 19.1 | |
| P/S | 0.9 | 0.6 | 0.4 | 0.6 | 1.2 | 1.2 | · | 1.7 | 1.5 | 2.0 | |
| P/B | 2.0 | 1.5 | 0.9 | 1.4 | 2.6 | 2.8 | · | 0.9 | 1.6 | 2.3 | |
| P / Cash Flow | 6.5 | 5.5 | 5.7 | 7.4 | 30.4 | 10.3 | · | 10.0 | 9.8 | 14.1 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | 11.9 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 2.5 | |
| Earnings Yield | 9.1% | -9.1% | -7.8% | 5.3% | 5.6% | -38.9% | -64.2% | 8.9% | 6.5% | 5.2% |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $488M | $476M | $494M | $493M | $469M | $458M | $502M | $511M | $504M | $495M | $496M | $507M | $501M | $491M | $514M | $490M | |
| SG&A Expense | $61M | $60M | $66M | $61M | $56M | $59M | $64M | $58M | $57M | $60M | $53M | $57M | $58M | $59M | $51M | $58M | |
| Operating Expenses | $431M | $435M | $445M | $425M | $409M | $426M | $463M | $477M | $662M | $479M | $608M | $466M | $452M | $461M | $478M | $443M | |
| Operating Income | $57M | $42M | $49M | $68M | $60M | $32M | $39M | $34M | $-158M | $16M | $-111M | $40M | $48M | $30M | $36M | $47M | |
| Interest Expense | · | · | · | · | · | · | · | · | $10M | $11M | · | $10M | $11M | $10M | · | $10M | |
| Other Non-op | $-3M | $-3M | $-3M | $20M | $-5M | $-4M | $-6M | $-9M | $-10M | $-8M | $-27M | $-9M | $-10M | $-9M | $-8M | $-9M | |
| Pretax Income | $54M | $39M | $46M | $88M | $55M | $28M | $33M | $25M | $-168M | $8M | $-139M | $31M | $39M | $21M | $28M | $39M | |
| Income Tax | $14M | $9M | $12M | $16M | $16M | $7M | $3M | $6M | $-15M | $4M | $-15M | $9M | $11M | $7M | $4M | $10M | |
| Net Income | $40M | $30M | $34M | $72M | $39M | $21M | $30M | $19M | $-153M | $4M | $-124M | $21M | $28M | $14M | $30M | $31M | |
| EPS (Basic) | $0.50 | $0.37 | $0.41 | $0.85 | $0.46 | $0.25 | $0.37 | $0.23 | $-1.84 | $0.05 | $-1.50 | $0.26 | $0.34 | $0.17 | $0.35 | $0.37 | |
| EPS (Diluted) | $0.49 | $0.36 | $0.40 | $0.84 | $0.46 | $0.24 | $0.37 | $0.23 | $-1.84 | $0.05 | $-1.50 | $0.26 | $0.34 | $0.17 | $0.35 | $0.37 | |
| Shares (Basic) | 79,440,000 | 80,881,000 | -169,761,000 | 84,609,000 | 84,797,000 | 84,435,000 | -166,756,000 | 83,891,000 | 83,332,000 | 82,863,000 | -164,635,000 | 82,543,000 | 82,399,000 | 81,894,000 | -169,142,000 | 82,126,000 | |
| Shares (Diluted) | 81,412,000 | 83,075,000 | -171,304,000 | 85,613,000 | 85,529,000 | 85,430,000 | -167,800,000 | 84,523,000 | 83,332,000 | 83,275,000 | -165,731,000 | 82,950,000 | 82,664,000 | 82,318,000 | -169,679,000 | 82,776,000 | |
| EBITDA | $63M | $48M | · | $74M | $65M | $37M | · | $40M | $-149M | $26M | · | $49M | $57M | $39M | · | $56M |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $289M | $206M | $375M | $340M | $225M | $99M | $230M | $104M | $19M | $8M | · | $21M | $6M | $6M | · | $9M | |
| Receivables | $228M | $225M | $230M | $231M | $239M | $243M | $260M | $287M | $274M | $284M | · | $277M | $271M | $279M | · | $294M | |
| Prepaid Expense | $10M | $13M | $13M | $9M | $10M | $12M | $13M | $10M | $12M | $13M | · | $11M | $12M | $15M | · | $10M | |
| Other Current Assets | $7M | $8M | $9M | $10M | $8M | $8M | $5M | $9M | $10M | $10M | · | $8M | $10M | $12M | · | $10M | |
| Current Assets | $660M | $587M | $764M | $717M | $613M | $492M | $640M | $528M | $429M | $427M | · | $421M | $398M | $409M | · | $424M | |
| PP&E (Net) | $39M | $41M | $39M | $39M | $39M | $38M | $39M | $42M | $48M | $74M | · | $75M | $73M | $73M | · | $72M | |
| PP&E (Gross) | · | · | $172M | · | · | · | $166M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $132M | · | · | · | $127M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1.27B | $1.27B | $1.26B | $1.26B | $1.24B | $1.24B | $1.24B | $1.24B | $1.24B | $1.39B | $1.38B | $1.53B | $1.53B | $1.53B | · | $1.53B | |
| Intangibles | $15M | $16M | $17M | $15M | $9M | $10M | $12M | $13M | $10M | $19M | · | $15M | $17M | $17M | · | $20M | |
| Other Non-current Assets | $57M | $55M | $58M | $58M | $71M | $71M | $77M | $79M | $80M | $83M | · | $108M | $117M | $119M | · | $118M | |
| Total Assets | $2.13B | $2.07B | $2.25B | $2.20B | $2.10B | $1.99B | $2.15B | $2.08B | $2.00B | $2.17B | · | $2.33B | $2.31B | $2.32B | · | $2.33B | |
| Accounts Payable | $28M | $32M | $37M | $39M | $42M | $44M | $46M | $47M | $32M | $32M | · | $32M | $31M | $35M | · | $27M | |
| Current Liabilities | $502M | $443M | $459M | $393M | $341M | $271M | $434M | $373M | $310M | $247M | · | $350M | $320M | $284M | · | $352M | |
| Capital Leases | $23M | $27M | $26M | $28M | $30M | $31M | $32M | $40M | $49M | $48M | · | $48M | $43M | $44M | · | $46M | |
| Deferred Tax | $59M | $57M | $57M | $38M | $36M | $34M | $34M | $36M | $31M | $34M | · | $41M | $38M | $33M | · | $40M | |
| Other Non-current Liabilities | $32M | $30M | $30M | $34M | $33M | $31M | $33M | $33M | $32M | $33M | · | $31M | $32M | $38M | · | $43M | |
| Total Liabilities | $1.25B | $1.19B | $1.38B | $1.31B | $1.27B | $1.20B | $1.39B | $1.34B | $1.29B | $1.31B | · | $1.36B | $1.36B | $1.41B | · | $1.47B | |
| Common Stock | $812.0K | $821.0K | $830.0K | $858.0K | $869.0K | $858.0K | $859.0K | $859.0K | $858.0K | $840.0K | · | $839.0K | $838.0K | $836.0K | · | $830.0K | |
| Retained Earnings | $-14M | $-54M | $-83M | $-117M | $-189M | $-228M | $-249M | $-279M | $-298M | $-145M | · | $-25M | $-47M | $-75M | · | $-119M | |
| AOCI | $-386.0K | $77.0K | $610.0K | $446.0K | $137.0K | $-292.0K | $-1M | $-209.0K | $-2M | $-2M | · | $-4M | $-4M | $-3M | · | $-4M | |
| Stockholders' Equity | $881M | $879M | $866M | $891M | $834M | $789M | $765M | $732M | $706M | $856M | · | $968M | $942M | $910M | · | $859M | |
| Liabilities + Equity | $2.13B | $2.07B | $2.25B | $2.20B | $2.10B | $1.99B | $2.15B | $2.08B | $2.00B | $2.17B | · | $2.33B | $2.31B | $2.32B | · | $2.33B | |
| Shares Outstanding | 81,222,774 | 82,061,119 | 82,976,110 | 85,832,837 | 86,854,234 | 85,810,408 | 85,866,000 | 85,865,841 | 85,753,258 | 84,008,436 | · | 83,929,000 | 83,841,000 | 83,634,000 | · | 83,006,000 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $6M | $5M | $5M | $7M | $6M | $9M | $10M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Stock-based Comp | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $4M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | |
| Deferred Tax | $11M | $8M | $25M | $11M | $12M | $4M | $14M | $9M | $-26M | $686.0K | $-7M | $2M | $6M | $2M | $-14M | $-7M | |
| Restructuring | $8M | $5M | $6M | $6M | $4M | $7M | $24M | $19M | $14M | $8M | $2M | $0 | $0 | $0 | $20M | $977.0K | |
| Other Non-cash | · | $-179M | · | · | · | $-152M | · | · | · | $-143M | · | · | · | $-129M | · | · | |
| Operating Cash Flow | $125M | $-130M | $114M | $137M | $137M | $-117M | $133M | $92M | $107M | $-125M | $69M | $80M | $89M | $-101M | $99M | $83M | |
| Investing Cash Flow | $6M | $-12M | $-10M | $7M | $-7M | $-7M | $-2M | $-4M | $-13M | $-16M | $-12M | $-14M | $-10M | $-11M | $-11M | $-6M | |
| Stock Issued | $1M | $544.0K | $646.0K | $700.0K | $1M | $662.0K | $732.0K | $897.0K | $1M | $860.0K | $1M | $1M | $2M | $1M | $1M | $1M | |
| Stock Repurchased | $43M | $21M | $64M | $21M | $209.0K | $2M | $643.0K | $162.0K | $11.0K | $887.0K | $0 | $133.0K | $11.0K | $775.0K | $1M | $21M | |
| Net Stock Activity | · | $-21M | · | · | · | $-907.0K | · | · | · | $-27.0K | · | · | · | $320.0K | · | · | |
| Financing Cash Flow | $-48M | $-28M | $-69M | $-29M | $-4M | $-6M | $-5M | $-3M | $-83M | $76M | $-5M | $-51M | $-79M | $109M | $-86M | $-83M | |
| Net Change in Cash | $83M | $-169M | $35M | $115M | $126M | $-131M | $126M | $84M | $11M | $-65M | $52M | $15M | $-275.0K | $-4M | $1M | $-5M |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.7% | 8.8% | · | 13.8% | 12.8% | 7.0% | · | 6.6% | -31.3% | 3.2% | · | 8.0% | 9.7% | 6.1% | · | 9.7% | |
| Net Margin | 8.2% | 6.2% | · | 14.5% | 8.4% | 4.5% | · | 3.8% | -30.3% | 0.81% | · | 4.2% | 5.7% | 2.9% | · | 6.3% | |
| Pretax Margin | 11.1% | 8.2% | · | 17.8% | 11.7% | 6.1% | · | 4.9% | -33.3% | 1.6% | · | 6.1% | 7.8% | 4.2% | · | 7.9% | |
| EBITDA Margin | 12.8% | 10.0% | · | 14.9% | 13.9% | 8.2% | · | 7.8% | -29.5% | 5.3% | · | 9.8% | 11.5% | 7.9% | · | 11.5% | |
| ROA | 1.9% | 1.5% | · | 3.4% | 1.9% | 1.0% | · | 0.88% | -7.1% | 0.18% | · | 0.92% | 1.2% | 0.61% | · | 1.2% | |
| ROE | 4.7% | 3.5% | · | 8.8% | 5.1% | 2.5% | · | 2.3% | -18.6% | 0.46% | · | 2.3% | 3.2% | 1.6% | · | 3.6% | |
| ROIC | 4.8% | 3.6% | · | 6.2% | 5.1% | 3.0% | · | 3.6% | -20.4% | 0.96% | · | 2.9% | 3.7% | 2.3% | · | 4.1% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | · | 1.8 | 1.8 | 1.8 | · | 1.4 | 1.4 | 1.7 | · | 1.2 | 1.2 | 1.4 | · | 1.2 | |
| Quick Ratio | 1.0 | 1.0 | · | 1.5 | 1.4 | 1.3 | · | 1.0 | 0.9 | 1.2 | · | 0.9 | 0.9 | 1.0 | · | 0.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -15.3 | 1.5 | · | 3.9 | 4.3 | 2.9 | · | 5.0 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 2.0 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.9 | 1.8 | · | 1.8 | 1.7 | 1.6 | · | 1.8 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.93B | $1.90B | · | $1.93B | $1.94B | $1.97B | · | $2.02B | $2.01B | $1.99B | · | $1.99B | $1.97B | $1.95B | · | $1.95B | |
| Net Income TTM | $180M | $161M | · | $151M | $-74M | $-109M | · | $-108M | $-99M | $68M | · | $95M | $100M | $51M | · | $67M | |
| Market Cap | $2.06B | $1.76B | · | $1.44B | $1.25B | $1.24B | · | $995M | $647M | $843M | · | $1.07B | $1.19B | $1.25B | · | $1.37B | |
| P/E | 11.8 | 11.3 | · | 9.5 | -15.8 | -11.0 | · | -8.9 | -6.3 | 12.2 | · | 11.1 | 11.8 | 24.4 | · | 20.6 | |
| P/S | 1.1 | 0.9 | · | 0.7 | 0.6 | 0.6 | · | 0.5 | 0.3 | 0.4 | · | 0.5 | 0.6 | 0.6 | · | 0.7 | |
| P/B | 2.3 | 2.0 | · | 1.6 | 1.5 | 1.6 | · | 1.4 | 0.9 | 1.0 | · | 1.1 | 1.3 | 1.4 | · | 1.6 | |
| P / Cash Flow | · | -13.5 | · | · | · | -10.6 | · | · | · | -6.7 | · | · | · | -12.4 | · | · | |
| Earnings Yield | 8.5% | 8.9% | · | 10.6% | -6.3% | -9.1% | · | -11.2% | -15.8% | 8.2% | · | 9.0% | 8.4% | 4.1% | · | 4.9% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B |
| 营业利润率 % | 10.9% | -3.4% | 0.37% | 8.8% | 10.6% |
| 净收入 | $165M | $-99M | $-60M | $66M | $131M |
| 稀释后每股收益 (EPS) | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 1.7 | 1.5 | 1.2 | 1.0 | 2.0 |
| 速动比率 | 1.3 | 1.1 | 0.9 | 0.7 | 1.6 |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 321 家申报者 · $1.4B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 46 (+2 与上一季度对比) | 28 (-8 与上一季度对比) | 100 (-4 与上一季度对比) | 99 (+7 与上一季度对比) | -2.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 45 位内幕人士 · 21 位高管 · 17 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Mark S Ordan | Chief Executive Officer | 2026年6月2日 A | 410884 | 0 | 1 | $-515430 |
| James D Swift | Chief Executive Officer | 2024年8月30日 S | 170001 | 0 | 0 | $0 |
| Kasandra H Rossi | EVP, CFO and Treasurer | 2026年6月1日 F | 101399 | 0 | 0 | $0 |
| Marc C Richards | EVP, Chief Financial Officer | 2024年8月12日 S | 175347 | 0 | 0 | $0 |
| Stephen D Farber | Former Chief Financial Officer | 2020年7月31日 G | 78027 | 0 | 0 | $0 |
| Vivian Lopez-Blanco | Chief Financial Officer | 2018年6月12日 S | 100590 | 0 | 0 | $0 |
| Joseph M Calabro | President | 2019年6月1日 F | 414679 | 0 | 0 | $0 |
| Karl B Wagner | President, Eastern Division | 2016年6月7日 S | 105932 | 0 | 0 | $0 |
| Michael D Stanley | President, Clinical Services | 2016年6月1日 S | 35247 | 0 | 0 | $0 |
| Frederick V Miller | President, Pediatrix Division | 2011年6月10日 S | 20781 | 0 | 0 | $0 |
| Curtis Pickert | EVP, Chief Operating Officer | 2024年6月1日 G | 118318 | 0 | 0 | $0 |
| David A. Clark | Chief Operating Officer | 2019年12月1日 F | 123032 | 0 | 0 | $0 |
| William C Hawk | COO American Anesthesiology | 2015年1月30日 S | 11550 | 0 | 0 | $0 |
| David Haddock | EVP, GC & Corp Sec | 2026年6月22日 A | 20036 | 0 | 0 | $0 |
| Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | 2026年6月9日 G | 111831 | 0 | 0 | $0 |
| Don Gregory Neeb | EVP, Chief Invest & Strategy | 2026年6月1日 F | 137231 | 0 | 0 | $0 |
| Lee Wood | EVP, Natl & Market Operations | 2024年6月1日 F | 117281 | 0 | 0 | $0 |
| Dominic J Andreano | EVP, General Counsel and Secy | 2022年9月26日 F | 189440 | 0 | 0 | $0 |
| Roger Mack Hinson | Pres., PDX & OBX Medical Group | 2022年3月1日 F | 109457 | 0 | 0 | $0 |
| John C Pepia | Principal Accounting Officer | 2021年11月10日 S | 96666 | 0 | 0 | $0 |
| Thomas W Hawkins | SVP, General Counsel and Secy. | 2012年2月21日 S | 43297 | 0 | 0 | $0 |
| Sylvia Jean Young | 董事 | 2026年8月14日 D | 29786 | 0 | 0 | $0 |
| Roger Medel MD | 董事 | 2022年5月12日 A | 747930 | 0 | 0 | $0 |
| Karey D Barker | 董事 | 2021年5月12日 A | 22663 | 0 | 0 | $0 |
| Waldemar A Carlo | 董事 | 2021年5月12日 A | 36687 | 0 | 0 | $0 |
| Paul G Gabos | 董事 | 2021年5月12日 A | 29198 | 0 | 0 | $0 |
| Carlos A Migoya | 董事 | 2020年2月13日 A | 12062 | 0 | 0 | $0 |
| Pascal J Goldschmidt | 董事 | 2020年2月13日 A | 15538 | 0 | 0 | $0 |
| Cesar L Alvarez | 董事 | 2020年2月13日 A | 48403 | 0 | 0 | $0 |
| Enrique Sosa | 董事 | 2020年2月13日 A | 37350 | 0 | 0 | $0 |
| Michael Fernandez | 董事 | 2020年2月13日 A | 355005 | 0 | 0 | $0 |
| Donna E Shalala | 董事 | 2018年3月1日 A | 16947 | 0 | 0 | $0 |
| Roger K Freeman | 董事 | 2014年6月1日 A | 7013 | 0 | 0 | $0 |
| Dany Garcia | 董事 | 2011年5月5日 A | — | 0 | 0 | $0 |
| Lawrence Mullen | 董事 | 2006年5月4日 A | — | 0 | 0 | $0 |
| John K Carlyle | 董事 | 2004年5月21日 M | 0 | 0 | 0 | $0 |
| Kurt Douglas Newman | — | 2026年8月12日 A | 17405 | 0 | 0 | $0 |
| Thomas Mceachin | — | 2026年8月12日 A | 7668 | 0 | 0 | $0 |
| Shirley A Weis | — | 2026年8月12日 A | 19095 | 0 | 1 | $-855665 |
| Michael A. Rucker | — | 2026年8月12日 A | 66769 | 0 | 1 | $-240994 |
| John M. Starcher Jr. | — | 2026年8月12日 A | 73732 | 0 | 0 | $0 |
| Laura A Linynsky | — | 2026年8月12日 A | 39900 | 0 | 1 | $-216500 |
| Guy P Sansone | — | 2026年8月12日 A | 87416 | 0 | 0 | $0 |
| Manuel Kadre | — | 2021年5月12日 A | 129198 | 0 | 0 | $0 |
| Nicholas Nikolopoulos | — | 2020年9月15日 S | 71954 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 8 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| STARBOARD VALUE LP, STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD, STARBOARD VALUE AND OPPORTUNITY S LLC, STARBOARD VALUE AND OPPORTUNITY C LP, STARBOARD VALUE R LP, STARBOARD VALUE R GP LLC, STARBOARD VALUE AND OPPORTUNITY MASTER FUND L LP, STARBOARD VALUE L LP, STARBOARD X MASTER FUND LTD, STARBOARD VALUE GP LLC, STARBOARD PRINCIPAL CO LP, STARBOARD PRINCIPAL CO GP LLC, JEFFREY C. SMITH, PETER A. FELD ×7 申报 | 2023年1月20日 | — | 初始申报 | — | SEC |
| Elliott Associates, L.P., Elliott International, L.P., Elliott International Capital Advisors Inc. ×2 申报 | 2018年9月20日 | — | 初始申报 | — | SEC |
| 2002年6月4日 | — | 初始申报 | — | SEC | |
| 2002年5月16日 | — | 初始申报 | — | SEC | |
| 2001年11月21日 | — | 初始申报 | — | SEC | |
| 2001年8月28日 | — | 初始申报 | — | SEC | |
| 2001年5月29日 | — | 初始申报 | — | SEC | |
| 2001年5月22日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 81 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| ABLS · Abacus FCF ETF Trust | 2.38% | 1297 NS | 2026年4月30日 | N-PORT |
| SIXS · EXCHANGE TRADED CONCEPTS TRUST | 1.23% | 72373 NS | 2026年5月31日 | N-PORT |
| ROSC · Lattice Strategies Trust | 1.02% | 24946 NS | 2026年4月30日 | N-PORT |
| VAMO · Cambria ETF Trust | 0.91% | 33476 NS | 2026年4月30日 | N-PORT |
| BRNY · EA Series Trust | 0.47% | 114985 NS | 2026年4月30日 | N-PORT |
| FYT · First Trust Exchange-Traded Alpha... | 0.37% | 29882 NS | 2026年4月30日 | N-PORT |
| SMIZ · Zacks Trust | 0.34% | 40147 NS | 2026年5月31日 | N-PORT |
| CALF · Pacer Funds Trust | 0.33% | 505185 NS | 2026年4月30日 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund ... | 0.30% | 13883 NS | 2026年5月31日 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.27% | 70041 NS | 2026年4月30日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.24% | 129825 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.16% | 200879 NS | 2026年5月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.11% | 114536 NS | 2026年4月30日 | N-PORT |
| SMDX · Tidal Trust III | 0.11% | 6075 NS | 2026年4月30日 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0.11% | 448999 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.10% | 32006 NS | 2026年4月30日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.09% | 312606 NS | 2026年4月30日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.09% | 41037 NS | 2026年5月31日 | N-PORT |
| SAA · ProShares Trust | 0.08% | 1006 NS | 2026年5月31日 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0.08% | 72885 NS | 2026年6月30日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.08% | 466319 NS | 2026年4月30日 | N-PORT |
| FAB · First Trust Exchange-Traded Alpha... | 0.08% | 4649 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.06% | 36992 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.05% | 4020 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 268275 NS | 2026年4月30日 | N-PORT |
| EBI · RBB Fund Trust | 0.04% | 11859 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.04% | 404911 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 39438 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.03% | 3144 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.02% | 20122 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.02% | 3182 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 2556 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 218554 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 3519 NS | 2026年5月31日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.01% | 5105 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 80 NS | 2026年5月31日 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.01% | 760 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 7666 NS | 2026年4月30日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 4262 NS | 2026年4月30日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 20817 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 24638 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 51908 NS | 2026年5月31日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.00% | 282 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VBR · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VFQY · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |